Cargando…

Oxidative Stress Markers in Hypertrophic Cardiomyopathy

Background and Objectives: Hypertrophic cardiomyopathy (HCM) depends on the primary impairment of sarcomeres, but it can also be associated with secondary alterations in the heart related to oxidative stress. The present study aimed to examine oxidative-antioxidant disturbances in patients with HCM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyguła-Jurkiewicz, Bożena, Szczurek-Wasilewicz, Wioletta, Osadnik, Tadeusz, Frycz-Kurek, Anna M., Macioł-Skurk, Karolina, Małyszek-Tumidajewicz, Justyna, Skrzypek, Michał, Romuk, Ewa, Gąsior, Mariusz, Banach, Maciej, Jóźwiak, Jacek J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781272/ https://www.ncbi.nlm.nih.gov/pubmed/35056338 http://dx.doi.org/10.3390/medicina58010031

Ejemplares similares

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Prognostic scales in advanced heart failure
por: Szczurek, Wioletta, et al.
Publicado: (2018)

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

A systematic approach to transoesophageal echocardiography in the intensive care unit – a practical guide for intensivists
por: Mielnicki, Wojciech, et al.
Publicado: (2021)

The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2016)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation
por: Osadnik, Tadeusz, et al.
Publicado: (2015)

Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis
por: Morze, Jakub, et al.
Publicado: (2020)

Transcatheter aortic valve implantation in moderate bicuspid aortic valve disease in a patient with end-stage dilated cardiomyopathy – bridge to heart transplantation
por: Mizia-Szubryt, Magdalena, et al.
Publicado: (2021)

Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology
por: Osadnik, Tadeusz, et al.
Publicado: (2019)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
por: Lewek, Joanna, et al.
Publicado: (2023)

Calcium and Phosphate Levels are Among Other Factors Associated with Metabolic Syndrome in Patients with Normal Weight
por: Osadnik, Kamila, et al.
Publicado: (2020)

Right Ventricular Free Wall Strain RVFWS as a Predictor of Outcome in Heart Transplantation Patients with COVID19 Disease
por: Malyszek Tumidajewicz, J., et al.
Publicado: (2022)

Challenges in Heart Transplantation in COVID 19 Pandemic New Biopsy Protocol a Single Center Experience
por: Tumidajewicz, J. Malyszek, et al.
Publicado: (2022)

Impact of vitamin D receptor polymorphisms in selected metabolic disorders
por: Fronczek, Martyna, et al.
Publicado: (2023)

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
por: Osadnik, Tadeusz, et al.
Publicado: (2017)

Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
por: Osadnik, Tadeusz, et al.
Publicado: (2023)

Metabolically healthy obese and metabolic syndrome of the lean: the importance of diet quality. Analysis of MAGNETIC cohort
por: Osadnik, Kamila, et al.
Publicado: (2020)

The Prognostic Role of Red Blood Cell Distribution Width in Coronary Artery Disease: A Review of the Pathophysiology
por: Bujak, Kamil, et al.
Publicado: (2015)

Evaluation of Usefulness of hs-CRP and Ferritin Assays in Patients with Nasal Polyps
por: Partyka, Robert, et al.
Publicado: (2014)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
por: Romuk, Ewa, et al.
Publicado: (2020)

Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2013)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center
por: Wasilewski, Jarosław, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5c93p9kmkrneic73vn17gajhg3